RxDoctor Payments Data

Nichole Stanley, APRN

Gerontology · Naples, FLNPI 1154976595

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $14,714 of the $18,500 with a category attached, or 79.5%. It is spread thinly across 36 manufacturers, the largest accounting for just 19.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $7,359, 3.2 times the $2,313 reported in 2021. Among gerontology clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$18,500in general payments, 2019–2025

Across 625 payments — averaging $29.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$4K
  • AstraZeneca$2K
  • Sanofi$2K
  • GSK$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$999
  • United Therapeutics Corporation$872
  • plus $7K from 30 others

What the payments were for

  • Consulting fees$1,2607%
  • Travel & lodging$2,26312%
  • Food & beverage$14,71480%
  • Education$2631%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$18,500 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida

Medicare billing

Part B allowed, 2024
$8,735
Medicare patients
111
Services billed
165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter208$265,558
GlassiaAlpha-1-Proteinase Inhibitor22$170,522
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr126$105,419
Breo ElliptaFluticasone/Vilanterol116$92,604
Breztri AerosphereBudesonide/Glycopyr/Formoterol65$68,322
NucalaMepolizumab15$64,326
Spiriva RespimatTiotropium Bromide67$61,181
Stiolto RespimatTiotropium Br/Olodaterol Hcl39$38,030
SymbicortBudesonide/Formoterol Fumarate67$25,430
Incruse ElliptaUmeclidinium Bromide23$17,636
EliquisApixaban19$16,610
Albuterol Sulfate HfaAlbuterol Sulfate364$11,327
Arnuity ElliptaFluticasone Furoate23$8,085
Fluticasone-SalmeterolFluticasone Propion/Salmeterol33$4,147
Ipratropium Bromide124$3,975

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta, Nucala, Incruse Ellipta$1,599$553,629511 claims
Takeda Pharmaceuticals U.S.A., Inc.Glassia$999$170,52222 claims
Boehringer IngelheimSpiriva Respimat, Stiolto Respimat$744$99,212106 claims
AstraZenecaBreztri Aerosphere, Symbicort$2,343$93,752132 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 714 gerontology providers in Florida.

Other gerontology in Naples

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →